Mitochondrial DNA copy number in patients with systemic sclerosis

Area of Science:

• Immunology
• Autoimmune Diseases
• Mitochondrial Biology

Background:

• Systemic scleroderma (SSc) is a chronic autoimmune disease involving inflammation and fibrosis.
• Mitochondrial dysfunction is implicated in SSc pathogenesis.
• Mitochondrial DNA (mtDNA) copy number serves as a marker for mitochondrial dysfunction.

Purpose of the Study:

• To investigate mtDNA copy number in CD14+ monocytes and whole blood of SSc patients versus healthy controls.
• To explore the relationship between mtDNA copy number and disease characteristics, including monocyte activation.

Main Methods:

• Digital PCR was used to quantify absolute mtDNA copy number.
• Analysis included CD14+ monocytes and whole blood samples.
• Correlation analyses were performed with disease duration and IL-6 secretion.

Main Results:

• Significantly higher mtDNA copy number was observed in CD14+ monocytes of SSc patients compared to controls.
• No significant difference in mtDNA copy number was found in whole blood.
• Inverse association between mtDNA copy number and disease duration was noted.
• Elevated IL-6 secretion (basal and LPS-stimulated) by SSc monocytes correlated with mtDNA copy number.

Conclusions:

• Increased mtDNA copy number in CD14+ monocytes may represent a compensatory response to mitochondrial defects in SSc.
• This finding offers insights into the role of monocytes in SSc pathogenesis and progression.